We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
59 result(s) found, displaying 21 to 30
-
Prescription medicine registrationActive ingredients: dolutegravir and dolutegravir (as sodium).
-
Prescription medicine registrationActive ingredients: dolutegravir and dolutegravir (as sodium).
-
Designation or determinationPriority review
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DOVATO 50/300 dolutegravir (as sodium) 50 mg/lamivudine 300 mg tablet bottle.
-
-
Prescription medicine registrationActive ingredients: fostemsavir trometamol.
-
Cancellation by sponsorRequested by ViiV Healthcare Pty Ltd
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Cabotegravir sodium and cabotegravir/rilpivirine
-
-
Prescription medicine registrationActive ingredients: cabotegravir; rilpivirine.